Filing Details

Accession Number:
0001209191-12-016316
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-07 09:01:44
Reporting Period:
2012-03-06
Filing Date:
2012-03-07
Accepted Time:
2012-03-07 09:01:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
858803 Avanir Pharmaceuticals Inc. AVNR Pharmaceutical Preparations (2834) 330314804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190315 Charles Mathews 20 Enterprise, Suite 200
Aliso Viejo CA 92656
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-06 5,000 $2.69 5,000 No 4 P Indirect By The Mathews Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By The Mathews Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 270,094 Direct
Common Stock 1,875 Indirect By Individual Retirement Account
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.68 to $2.6993, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. Consists of (i) 267,594 shares underlying restricted stock units granted under the Issuer's equity plans, and (ii) 2,500 shares of common stock held by Mr. Mathews.